Discovery of Orexant and Anorexant Agents with Indazole Scaffold Endowed with Peripheral Antiedema Activity

Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex

(2019) Kaavya Krishna Kumar et al.   CELL

Fatal intoxication with new synthetic cannabinoids AMB-FUBINACA and EMB-FUBINACA

(2019) Piotr Adamowicz et al.   CLINICAL TOXICOLOGY

Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptors

(2019) Szabolcs Dvorácskó et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Structural Insights into CB1 Receptor Biased Signaling

(2019) Al-Zoubi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Long-Lasting Anti-Inflammatory and Antinociceptive Effects of Acute Ammonium Glycyrrhizinate Administration: Pharmacological, Biochemical, and Docking Studies

(2019) Francesco Maione et al.   MOLECULES

On resin click-chemistry-mediated synthesis of novel enkephalin analogues with potent anti-nociceptive activity

(2019) Azzurra Stefanucci et al.   Scientific Reports

Pharmacological evaluation of new constituents of “Spice”: synthetic cannabinoids based on indole, indazole, benzimidazole and carbazole scaffolds

(2018) Clara T. Schoeder et al.   Forensic Toxicology

Novel Fubinaca/Rimonabant hybrids as endocannabinoid system modulators

(2018) Azzurra Stefanucci et al.   AMINO ACIDS

Psychosis and synthetic cannabinoids

(2018) Huiqiong Deng et al.   PSYCHIATRY RESEARCH

Synthetic cannabinoids: Variety is definitely not the spice of life

(2018) Alan M. Langford et al.   Journal of Forensic and Legal Medicine

THC for Chronic Pain

(2018) Anita Slomski   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Motor vehicle collisions caused by the ‘super-strength’ synthetic cannabinoids, MAM-2201, 5F-PB-22, 5F-AB-PINACA, 5F-AMB and 5F-ADB in Japan experienced from 2012 to 2014

(2017) Shuji Kaneko   Forensic Toxicology

Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors

(2017) Adriano Mollica et al.   JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Opioid Receptor Activity and Analgesic Potency of DPDPE Peptide Analogues Containing a Xylene Bridge

(2017) Azzurra Stefanucci et al.   ACS Medicinal Chemistry Letters

Health and Social Problems Associated with Recent Novel Psychoactive Substance (NPS) Use Amongst Marginalised, Nightlife and Online Users in Six European Countries

(2017) Marie Claire Van Hout et al.   International Journal of Mental Health and Addiction

Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues

(2016) Samuel D. Banister et al.   ACS Chemical Neuroscience

To eat or not to eat? Indicators for reduced food intake in 91,245 patients hospitalized on nutritionDays 2006–2014 in 56 countries worldwide: a descriptive analysis

(2016) Karin Schindler et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations

(2016) Francesco Rubino et al.   DIABETES CARE

Death Associated With the Use of the Synthetic Cannabinoid ADB-FUBINACA

(2016) Kevin G. Shanks et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies

(2015) Adriano Mollica et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Experimental design and analysis and their reporting: new guidance for publication in BJP

(2015) Michael J Curtis et al.   BRITISH JOURNAL OF PHARMACOLOGY

Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP

(2015) John C McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease

(2015) Wilfrid Mazier et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Identifying predictors of blood pressure control in the Lebanese population - a national, multicentric survey – I-PREDICT

(2014) Samir G Mallat et al.   BMC PUBLIC HEALTH

Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications

(2014) Marisol S. Castaneto et al.   DRUG AND ALCOHOL DEPENDENCE

Orexigenic effects of endomorphin-2 (EM-2) related to decreased CRH gene expression and increased dopamine and norepinephrine activity in the hypothalamus

(2013) Luigi Brunetti et al.   PEPTIDES

Pharmacogenetics of drugs withdrawn from the market

(2012) Wei Zhang et al.   PHARMACOGENOMICS

Sibutramine on Cardiovascular Outcome

(2011) A. J. Scheen   DIABETES CARE

The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview

(2011) Ashly D. Black et al.   PLOS MEDICINE

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

Neuroanatomical basis for therapeutic applications of cannabinoid receptor 1 antagonists

(2009) Brian F. Thomas   DRUG DEVELOPMENT RESEARCH

Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis

(2009) David R Janero et al.   EXPERT OPINION ON EMERGING DRUGS

Prediction of the Water Content in Protein Binding Sites

(2009) Julien Michel et al.   JOURNAL OF PHYSICAL CHEMISTRY B

Effect of Rimonabant on the High-Triglyceride/ Low–HDL-Cholesterol Dyslipidemia, Intraabdominal Adiposity, and Liver Fat

(2008) Jean-Pierre Després et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus

(2007) E Soria-Gómez et al.   BRITISH JOURNAL OF PHARMACOLOGY

Pretreatment with subeffective doses of Rimonabant attenuates orexigenic actions of orexin A-hypocretin 1

(2007) Inmaculada Crespo et al.   NEUROPHARMACOLOGY